Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 99,594 | 200,317 | 107,667 | 91,641 | 102,827 |
| Marketable Securities | 617,990 | 552,923 | 463,699 | 521,546 | 374,543 |
| Other current assets | 0 | 14 | 0 | 102 | 102 |
| TOTAL | $738,461 | $767,357 | $581,664 | $626,818 | $486,478 |
| Non-Current Assets | |||||
| PPE Net | 1,236 | 1,290 | 1,514 | 1,526 | 1,672 |
| Other Non-Current Assets | 2,706 | 3,253 | 2,485 | 2,037 | 2,274 |
| TOTAL | $3,942 | $4,543 | $3,999 | $3,563 | $3,946 |
| Total Assets | $742,403 | $771,900 | $585,663 | $630,381 | $490,424 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,143 | 6,338 | 3,140 | 2,676 | 2,239 |
| Accrued Expenses | 45,731 | 34,738 | 30,370 | 23,163 | 24,108 |
| TOTAL | $47,874 | $41,364 | $36,762 | $26,127 | $26,635 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,582 | 20,523 | 17,487 | 20,328 | 20,205 |
| Deferred Revenues | N/A | 288 | 288 | 288 | 288 |
| Other Non-Current Liabilities | 2,308 | 2,161 | 1,648 | 896 | 989 |
| TOTAL | $22,890 | $23,040 | $19,563 | $21,724 | $21,767 |
| Total Liabilities | $70,764 | $64,404 | $56,325 | $47,851 | $48,402 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 81,485 | 79,213 | 63,890 | 63,822 | 62,768 |
| Common Shares | 810 | 792 | 639 | 638 | 540 |
| Retained earnings | -995,857 | -916,132 | -839,443 | -774,450 | -725,908 |
| Other shareholders' equity | 188,875 | 189,817 | 199,167 | 199,343 | 206,854 |
| TOTAL | $671,639 | $707,496 | $529,338 | $582,530 | $442,022 |
| Total Liabilities And Equity | $742,403 | $771,900 | $585,663 | $630,381 | $490,424 |